An article Anti-hyperlipidaemic effects of synthetic analogues of nordihydroguaiaretic acid in dyslipidaemic rats WOS:000455517100003 published article about FATTY LIVER-DISEASE; DE-NOVO LIPOGENESIS; HEPATIC LIPID-METABOLISM; TRIACYLGLYCEROL SYNTHESIS; DIABETES-MELLITUS; CONCISE GUIDE; NAFLD; PATHOGENESIS; SECRETION; ENZYMES in [Singh, Madhurima; Li, Yihang; Han, Lu; Shen, Wen-Jun; Kraemer, Fredric B.; Azhar, Salman] Stanford Univ, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA; [Singh, Madhurima; Bittner, Stefanie; Li, Yihang; Bittner, Alex; Han, Lu; Cortez, Yuan; Shen, Wen-Jun; Nicolls, Mark R.; Kraemer, Fredric B.; Azhar, Salman] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA; [Inayathullah, Mohammed; Rajadas, Jayakumar] BioADD Lab, Div Cardiovasc Pharmacol CVI, Stanford, CA USA; [Nicolls, Mark R.] Stanford Univ, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Arif, Zeeshan; Parthasarathi, Ramakrishnan] CSIR, Indian Inst Toxicol Res, Computat Toxicol Facil, Lucknow, Uttar Pradesh, India; [Singh, Madhurima] BD Becton Dickinson Biosci, San Jose, CA USA; [Li, Yihang] GenScript USA Inc, Piscataway, NJ USA in 2019.0, Cited 65.0. The Name is 1,1,1-Triethoxyethane. Through research, I have a further understanding and discovery of 78-39-7. Safety of 1,1,1-Triethoxyethane
Background and Purpose Previous studies have shown that Creosote bush-derived nordihydroguaiaretic acid (NDGA) exerts beneficial actions on the key components of metabolic syndrome including dyslipidaemia, insulin resistance and hypertension in several relevant rodent models. Here, we synthesized and screened a total of 6 anti-hyperlipidaemic analogues of NDGA and tested their efficacy against hepatic lipid metabolism in a high-fructose diet (HFrD) fed dyslipidaemic rat model. Experimental Approach HFrD fed Sprague-Dawley rats treated with NDGA or one of the six analogues were used. Serum samples were analysed for blood metabolites, whereas liver samples were quantified for changes in various mRNA levels by real-time RT-PCR. Key Results Oral gavage of HFrD-fed rats for 4 days with NDGA analogues 1 and 2 (100 mg center dot kg(-1)center dot day(-1)) suppressed the hepatic triglyceride content, whereas the NDGA analogues 2, 3 and 4, like NDGA, decreased the plasma triglyceride levels by 70-75%. qRT-PCR measurements demonstrated that among NDGA analogues 1, 2, 4 and 5, analogue 4 was the most effective at inhibiting the mRNA levels of some key enzymes and transcription factors involved in lipogenesis. All four analogues almost equally inhibited the key genes involved in triglyceride synthesis and fatty acid elongation. Unlike NDGA, none of the analogues affected the genes of hepatic fatty acid oxidation or transport. Conclusions and Implications Our data suggest that NDGA analogues 1, 2, 4 and 5, particularly analogue 4, exert their anti-hyperlipidaemic actions by negatively targeting genes of key enzymes and transcription factors involved in lipogenesis, triglyceride synthesis and fatty acid elongation. These analogues have therapeutic potential.
About 1,1,1-Triethoxyethane, If you have any questions, you can contact Singh, M; Bittner, S; Li, YH; Bittner, A; Han, L; Cortez, Y; Inayathullah, M; Arif, Z; Parthasarathi, R; Rajadas, J; Shen, WJ; Nicolls, MR; Kraemer, FB; Azhar, S or concate me.. Safety of 1,1,1-Triethoxyethane
Reference:
Thiazolidine – Wikipedia,
,Thiazolidine – ScienceDirect.com